C. O’Brien

Cochrane Database of Systematic Reviews

Botulinum neurotoxins in the treatment of refractory pain

Gastrointestinal dysfunction in Parkinson's disease

Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5–7, 1996

Epileptic seizures triggered directly by focal transcranial magnetic stimulation

Botulinum Toxin—A Treatment for Migraine? A Systematic Review

Clinical Comparisons of Botulinum Neurotoxin Formulations

Snakebite envenoming

Leg muscle activation during gait in Parkinson's disease: adaptation and interlimb coordination

Presynaptic Neurotoxins with Enzymatic Activities

Falls and freezing of gait in Parkinson's disease: A review of two interconnected, episodic phenomena

Botulinum toxin type B for cervical dystonia

Botulinum toxin B reduces sialorrhea in parkinsonism

Assessment of spatio-temporal gait parameters from trunk accelerations during human walking

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

Dissemination and publication of research findings: an updated review of related biases

A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson’s disease

Gait Analysis Using Wearable Sensors

Botulinum toxin A as treatment for drooling saliva in PD

Centrally Initiated Postural Adjustments in Parkinsonian Patients On and Off Levodopa

Voluntary and involuntary adaptation of gait in Parkinson's disease

Motor Disturbances II

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–resistant cervical dystonia